Evidence map›Paper›PMID 35682893›Full record

ArticleInternational journal of molecular sciences2022

Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo.

Oksana V Salomatina, Aleksandra V Sen'kova, Arseny D Moralev, Innokenty A Savin, Nina I Komarova, Nariman F Salakhutdinov, Marina A Zenkova, Andrey V Markov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. SoloxoloneInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. SoloxoloneMolecules (Basel, Switzerland) · 2024
    Article
  5. A Novel 3-ACS omega · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Oksana V SalomatinaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.
Aleksandra V Sen'kovaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.ORCID 0000-0001-5729-9910
Arseny D MoralevInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.
Innokenty A SavinInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.ORCID 0000-0002-3032-858X
Nina I KomarovaN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 9, 630090 Novosibirsk, Russia.
Nariman F SalakhutdinovN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 9, 630090 Novosibirsk, Russia.
Marina A ZenkovaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.ORCID 0000-0003-4044-1049
Andrey V MarkovInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Avenue, 8, 630090 Novosibirsk, Russia.ORCID 0000-0001-7569-9555
Institute of Chemical Biology and Fundamental Medicine · RUNovosibirsk Institute of Organic Chemistry · RUNovosibirsk State University · RU

Funding

Russian Science Foundation 17-75-20120Russian State funded budget project of ICBFM SB RAS 121031300044-5
6 · The paper itself

Abstract

It is known that epoxide-bearing compounds display pronounced pharmacological activities, and the epoxidation of natural metabolites can be a promising strategy to improve their bioactivity. Here, we report the design, synthesis and evaluation of biological properties of

Indexed as

Antineoplastic AgentsGlycyrrhetinic AcidNeoplasmsAnimalsAnti-Inflammatory AgentsEpoxy CompoundsEthylene OxideMiceStereoisomerismAnti-Inflammatory AgentsAntineoplastic AgentsEpoxy CompoundsEthylene OxideGlycyrrhetinic Acid18βH-glycyrrhetinic acidABC transportersanti-inflammatory activityanti-metastatic activityapoptosisCDDO-Meepoxidepharmacophore groupsoloxolone methyltoxicity

Identifiers

PMID35682893
PMCPMC9181525
OpenAlexW4281810586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.